Study calls for increased testing of STIs, in place of diagnosing based on symptoms alone, as many young Zimbabweans with an STI present with zero symptoms.
A study suggests vaginal bacteria may be playing an underestimated role in PrEP efficacy for women
National data from five Southern African countries suggests nearly 89% of adults on HIV treatment are virally suppressed – but gaps remain.
Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.
Malawians in some rural areas face travel times to HIV clinics that are almost double others’ journeys.
UChoose study is the first to assesses adolescent girls’ preferences for contraceptives that mirror PrEP products to establish what type of PrEP is most likely to work for them
Eswatini study reveals mixed views on PrEP among heterosexual men – driven by HIV-related stigma – amidst low uptake and high drop-out rates
Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months
Government initiative increases retention in care by a third but struggles to expand treatment access or reduce deaths among people with HIV.
Gay men and transgender women who have sex with men in Nairobi and Johannesburg are active social media users, possibly providing an untapped opportunity for sexual health promotion on these platforms.
User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.
An HIV testing initiative that targeted male-dominated workplaces and social spaces, and notified the sexual partners of anyone testing positive, results in 25% of men being diagnosed with HIV
New Kenyan trial providing HIV self-tests to sex workers sees high levels of partner testing – and increased condom use when men refused to test
Dutch study finds no evidence to suggest PrEP use increases mental health issues – and may actually help reduce sexual compulsivity and drug-misuse.
Research suggests women with disabilities are significantly more vulnerable to HIV than other women and disabled men – and that this is linked to sexual violence.
Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.
